Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0020505 (
hyperphagia
)
6,116
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Protein tyrosine phosphatase 1B
(
PTP1B
) is a known regulator of central metabolic signaling, and mice with whole brain-, leptin receptor (LepRb) expressing cell-, or proopiomelanocortin neuron-specific
PTP1B
-deficiency are lean, leptin hypersensitive, and display improved glucose homeostasis. However, whether the metabolic effects of central
PTP1B
-deficiency are due to action within the hypothalamus remains unclear. Moreover, whether or not these effects are exclusively due to enhanced leptin signaling is unknown. Here we report that mice with hypothalamic
PTP1B
-deficiency (Nkx2.1-
PTP1B
(-/-)) display decreased body weight and adiposity on high-fat diet with no associated improvements in glucose tolerance. Consistent with previous reports, we find that hypothalamic deletion of the LepRb in mice (Nkx2.1-LepRb(-/-)) results in extreme
hyperphagia
and obesity. Interestingly, deletion of hypothalamic
PTP1B
and LepRb (Nkx2.1-
PTP1B
(-/-):LepRb(-/-)) does not rescue the
hyperphagia
or obesity of Nkx2.1-LepRb(-/-) mice, suggesting that hypothalamic
PTP1B
contributes to the central control of energy balance through a leptin receptor-dependent pathway.
...
PMID:Improved metabolic phenotype of hypothalamic PTP1B-deficiency is dependent upon the leptin receptor. 2474 60